Intersect ENT, Inc. Deferred Tax Assets, Valuation Allowance
Intersect ENT, Inc. had Deferred Tax Assets, Valuation Allowance of $127.90 million as of 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2022-03-08
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $127.90M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $87.57M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $71.79M.
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $60.49M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2021-12-31 | $127.90M 10-K · filed 2022-03-08 |
| 2020-12-31 | $87.57M 10-K · filed 2022-03-08 |
| 2019-12-31 | $71.79M 10-K · filed 2021-03-09 |
| 2018-12-31 | $60.49M 10-K · filed 2020-02-27 |
| 2017-12-31 | $51.03M 10-K · filed 2019-02-28 |
| 2016-12-31 | $58.21M 10-K · filed 2018-02-28 |
| 2015-12-31 | $48.73M 10-K · filed 2017-02-28 |
| 2014-12-31 | $39.20M 10-K · filed 2016-02-25 |
| 2013-12-31 | $31.91M 10-K · filed 2015-03-11 |